Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Parkinson's Disease market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Parkinson's Diseasemarket, defines the market attractiveness level of Parkinson's Disease market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Parkinson's Disease industry, describes the types of Parkinson's Disease market, the applications of major players and the market size, and deeply analyzes the current situation of the global Parkinson's Disease market and the development prospects and opportunities of Parkinson's Disease industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Parkinson's Disease market in Chapter 13.
By Player:
Boehringer Ingelheim
AbbVie
Novartis
Acadia
UCB
Wockhardt
Impax
Teva
GSK
Valeant Pharmaceuticals
Lundbeck
Merck
Sun Pharma
By Type:
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
By End-User:
Medical Science
pharmacy
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Parkinson's Disease Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Parkinson's Disease Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Parkinson's Disease Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Parkinson's Disease Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Parkinson's Disease Market Analysis and Outlook to 2022
-
7.1 Global Parkinson's Disease Consumption (2017-2022)
-
7.2 United States Parkinson's Disease Consumption (2017-2022)
-
7.3 Europe Parkinson's Disease Consumption (2017-2022)
-
7.4 China Parkinson's Disease Consumption (2017-2022)
-
7.5 Japan Parkinson's Disease Consumption (2017-2022)
-
7.6 India Parkinson's Disease Consumption (2017-2022)
-
7.7 South Korea Parkinson's Disease Consumption (2017-2022)
8 Region and Country-wise Parkinson's Disease Market Analysis and Outlook to 2028
-
8.1 Global Parkinson's Disease Consumption Forecast (2022-2028)
-
8.2 United States Parkinson's Disease Consumption Forecast (2022-2028)
-
8.3 Europe Parkinson's Disease Consumption Forecast (2022-2028)
-
8.4 China Parkinson's Disease Consumption Forecast (2022-2028)
-
8.5 Japan Parkinson's Disease Consumption Forecast (2022-2028)
-
8.6 India Parkinson's Disease Consumption Forecast (2022-2028)
-
8.7 South Korea Parkinson's Disease Consumption Forecast (2022-2028)
9 Global Parkinson's Disease Market Outlook by Types and Applications to 2022
-
9.1 Global Parkinson's Disease Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Carbidopa/Levodopa Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dopamine Receptor Agonists Consumption and Growth Rate (2017-2022)
-
9.1.3 Global MAO-Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Parkinson's Disease Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medical Science Consumption and Growth Rate (2017-2022)
-
9.2.2 Global pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Parkinson's Disease Market Outlook by Types and Applications to 2028
-
10.1 Global Parkinson's Disease Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Carbidopa/Levodopa Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Dopamine Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global MAO-Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Parkinson's Disease Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Medical Science Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Parkinson's Disease Import and Export Analysis (Top 5 Countries)
-
11.1 Global Parkinson's Disease Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Parkinson's Disease Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Parkinson's Disease Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Parkinson's Disease Market Competitive Analysis
-
14.1 Boehringer Ingelheim
-
14.1.1 Boehringer Ingelheim Company Details
-
14.1.2 Boehringer Ingelheim Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Boehringer Ingelheim Parkinson's Disease Product and Service
-
14.2 AbbVie
-
14.2.1 AbbVie Company Details
-
14.2.2 AbbVie Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AbbVie Parkinson's Disease Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Parkinson's Disease Product and Service
-
14.4 Acadia
-
14.4.1 Acadia Company Details
-
14.4.2 Acadia Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Acadia Parkinson's Disease Product and Service
-
14.5 UCB
-
14.5.1 UCB Company Details
-
14.5.2 UCB Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 UCB Parkinson's Disease Product and Service
-
14.6 Wockhardt
-
14.6.1 Wockhardt Company Details
-
14.6.2 Wockhardt Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Wockhardt Parkinson's Disease Product and Service
-
14.7 Impax
-
14.7.1 Impax Company Details
-
14.7.2 Impax Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Impax Parkinson's Disease Product and Service
-
14.8 Teva
-
14.8.1 Teva Company Details
-
14.8.2 Teva Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Teva Parkinson's Disease Product and Service
-
14.9 GSK
-
14.9.1 GSK Company Details
-
14.9.2 GSK Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GSK Parkinson's Disease Product and Service
-
14.10 Valeant Pharmaceuticals
-
14.10.1 Valeant Pharmaceuticals Company Details
-
14.10.2 Valeant Pharmaceuticals Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Valeant Pharmaceuticals Parkinson's Disease Product and Service
-
14.11 Lundbeck
-
14.11.1 Lundbeck Company Details
-
14.11.2 Lundbeck Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Lundbeck Parkinson's Disease Product and Service
-
14.12 Merck
-
14.12.1 Merck Company Details
-
14.12.2 Merck Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Merck Parkinson's Disease Product and Service
-
14.13 Sun Pharma
-
14.13.1 Sun Pharma Company Details
-
14.13.2 Sun Pharma Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Sun Pharma Parkinson's Disease Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Parkinson's Disease
-
Figure Parkinson's Disease Picture
-
Table Global Parkinson's Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Parkinson's Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Parkinson's Disease Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Parkinson's Disease Consumption by Country (2017-2022)
-
Figure United States Parkinson's Disease Consumption and Growth Rate (2017-2022)
-
Table Europe Parkinson's Disease Consumption and Growth Rate (2017-2022)
-
Figure China Parkinson's Disease Consumption and Growth Rate (2017-2022)
-
Figure Japan Parkinson's Disease Consumption and Growth Rate (2017-2022)
-
Figure India Parkinson's Disease Consumption and Growth Rate (2017-2022)
-
Figure South Korea Parkinson's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Parkinson's Disease Consumption Forecast by Country (2022-2028)
-
Figure United States Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Carbidopa/Levodopa Consumption and Growth Rate (2017-2022)
-
Figure Global Dopamine Receptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global MAO-Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Science Consumption and Growth Rate (2017-2022)
-
Figure Global pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Carbidopa/Levodopa Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dopamine Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MAO-Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Science Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Parkinson's Disease Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Parkinson's Disease Export by Region (Top 5 Countries) (2017-2028)
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Parkinson's Disease Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Parkinson's Disease Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Parkinson's Disease Product and Service
-
Table Acadia (Foundation Year, Company Profile and etc.)
-
Table Acadia Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acadia Parkinson's Disease Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Parkinson's Disease Product and Service
-
Table Wockhardt (Foundation Year, Company Profile and etc.)
-
Table Wockhardt Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wockhardt Parkinson's Disease Product and Service
-
Table Impax (Foundation Year, Company Profile and etc.)
-
Table Impax Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Impax Parkinson's Disease Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Parkinson's Disease Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Parkinson's Disease Product and Service
-
Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals Parkinson's Disease Product and Service
-
Table Lundbeck (Foundation Year, Company Profile and etc.)
-
Table Lundbeck Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lundbeck Parkinson's Disease Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Parkinson's Disease Product and Service
-
Table Sun Pharma (Foundation Year, Company Profile and etc.)
-
Table Sun Pharma Parkinson's Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharma Parkinson's Disease Product and Service
-
